Synthetic Lethal Interactions Between EGFR and PARP Inhibition in Triple Negative Breast Cancer

被引：0
|
作者：
Nowsheen, S. [1 ]
Cooper, T. [1 ]
LoBuglio, A. F. [1 ]
Bonner, J. A. [1 ]
Yang, E. S. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S176 / S177
页数：2
相关论文
共 50 条
  • [21] Rac1 inhibition to sensitize triple negative breast cancer to EGFR inhibition.
    Azzi, Georges
    Goka, Erik
    Senderoff, Dana
    Lippman, Marc E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence (vol 10, 2556, 2019)
    Fleury, Hubert
    Malaquin, Nicolas
    Tu, Veronique
    Gilbert, Sophie
    Martinez, Aurelie
    Olivier, Marc-Alexandre
    Sauriol, Skye Alexandre
    Communal, Laudine
    Leclerc-Desaulniers, Kim
    Carmona, Euridice
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Rodier, Francis
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [23] Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
    Prson Gautam
    Leena Karhinen
    Agnieszka Szwajda
    Sawan Kumar Jha
    Bhagwan Yadav
    Tero Aittokallio
    Krister Wennerberg
    Molecular Cancer, 15
  • [24] Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
    Gautam, Prson
    Karhinen, Leena
    Szwajda, Agnieszka
    Jha, Sawan Kumar
    Yadav, Bhagwan
    Aittokallio, Tero
    Wennerberg, Krister
    MOLECULAR CANCER, 2016, 15
  • [25] PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Jill J. J. Geenen
    Sabine C. Linn
    Jos H. Beijnen
    Jan H. M. Schellens
    Clinical Pharmacokinetics, 2018, 57 : 427 - 437
  • [26] PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Geenen, Jill J. J.
    Linn, Sabine C.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CLINICAL PHARMACOKINETICS, 2018, 57 (04) : 427 - 437
  • [27] EGFR INHIBITOR IN METASTATIC TRIPLE NEGATIVE BREAST CANCER
    Payandeh, M.
    Aeinfar, M.
    Zare, M. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 44 - 44
  • [28] Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
    Wang, Dong
    Du, Ruikai
    Liu, Suling
    CHINESE JOURNAL OF CANCER, 2017, 36
  • [29] EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer
    Liu, Xia
    Adorno-Cruz, Valery
    Chang, Ya-Fang
    Jia, Yuzhi
    Kawaguchi, Madoka
    Dashzeveg, Nurmaa K.
    Taftaf, Rokana
    Ramos, Erika K.
    Schuster, Emma J.
    El-Shennawy, Lamiaa
    Patel, Dhwani
    Zhang, Youbin
    Cristofanilli, Massimo
    Liu, Huiping
    THERANOSTICS, 2021, 11 (13): : 6632 - 6643
  • [30] Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
    Dong Wang
    Ruikai Du
    Suling Liu
    Chinese Journal of Cancer, 2017, 36 (06) : 245 - 246
12345